An Open Label Study of Itacitinib Administered Orally in Patients With Myelofibrosis

Birmingham Hematology Oncology Associates, LLC, Birmingham

Mayo Clinic, Arizona, Scottsdale

UCLA Hematology & Oncology, Los Angeles

Emory University, Atlanta

St Agnes Hospital, Baltimore

University of Michigan Cancer Center, Ann Arbor

Mount Sinai School of Medicine, New York

Oregon Health & Science University, Portland

University of Pennsylvania Health System, Philadelphia

Western Pennsylvania Hospital, Pittsburgh

South Carolina Oncology & Associates, Columbia

Boston Baskin Cancer Foundation, Inc., Memphis

Tennessee Oncology, Nashville

MD Anderson Cancer Center, Houston

St Vincent's Hospital, Darlinghurst

St. George Hospital, Kogarah

Box Hill Hospital, Box Hill

Frankston Hospital, Frankston

Cross Cancer Institute, Edmonton

St. Paul's Hospital, Vancouver

Princess Margaret Hospital, Toronto

St. Mary's Hospital, Montreal